We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
151
United Therapeutics
UTHR
$26.3B
$24.1M 0.14%
67,148
+2,635
+4% +$890K
NRIX icon
152
Nurix Therapeutics
NRIX
$2.43B
$23.9M 0.14%
1,061,959
-102,287
-9% -$2.32M
INTU icon
153
Intuit
INTU
$83.1B
$23.8M 0.14%
38,372
-16,459
-30% -$10.5M
BCYC
154
Bicycle Therapeutics
BCYC
$276M
$23.8M 0.14%
1,050,598
+291,418
+38% +$6.72M
MTB icon
155
M&T Bank
MTB
$36B
$23.7M 0.14%
133,229
-23,416
-15% -$3.88M
PDD icon
156
Pinduoduo
PDD
$121B
$23.3M 0.13%
172,500
-90,820
-34% -$11.2M
WMT icon
157
Walmart Inc
WMT
$889B
$23.1M 0.13%
285,751
+1,176
+0.4% +$86.4K
BMRN icon
158
BioMarin Pharmaceuticals
BMRN
$11.6B
$23M 0.13%
327,402
-197,736
-38% -$16.5M
PWR icon
159
Quanta Services
PWR
$93.1B
$22.9M 0.13%
76,655
+1,559
+2% +$412K
BSY icon
160
Bentley Systems
BSY
$10.2B
$22.7M 0.13%
446,961
+21,952
+5% +$1.08M
DGX icon
161
Quest Diagnostics
DGX
$25.6B
$22.6M 0.13%
145,829
+80,966
+125% +$12.1M
DE icon
162
Deere & Co
DE
$169B
$22.6M 0.13%
54,202
+34,542
+176% +$13M
WELL icon
163
Welltower
WELL
$175B
$22.6M 0.13%
176,242
-15,474
-8% -$1.81M
BZ icon
164
Kanzhun
BZ
$7.03B
$22.5M 0.13%
1,297,000
-762,000
-37% -$11.1M
APD icon
165
Air Products & Chemicals
APD
$65.2B
$22.4M 0.13%
75,268
-26,751
-26% -$7.32M
WMS icon
166
Advanced Drainage Systems
WMS
$11B
$22.3M 0.13%
141,620
-37,856
-21% -$5.91M
VRNA
167
DELISTED
Verona Pharma
VRNA
$22.2M 0.13%
772,997
– –
DECK icon
168
Deckers Outdoor
DECK
$13.6B
$21.8M 0.13%
136,754
-12,130
-8% -$1.85M
PK icon
169
Park Hotels & Resorts
PK
$3.03B
$21.7M 0.12%
1,541,137
-100,648
-6% -$1.47M
OC icon
170
Owens Corning
OC
$11.6B
$21.7M 0.12%
122,655
-21,877
-15% -$3.68M
FSLR icon
171
First Solar
FSLR
$22.1B
$21.3M 0.12%
85,551
+1,654
+2% +$372K
MAR icon
172
Marriott International
MAR
$101B
$21.3M 0.12%
85,753
+4,804
+6% +$1.12M
BRO icon
173
Brown & Brown
BRO
$23.6B
$21.3M 0.12%
205,211
+13,076
+7% +$1.3M
GIS icon
174
General Mills
GIS
$19.5B
$21.1M 0.12%
286,393
+187,668
+190% +$13M
TFC icon
175
Truist Financial
TFC
$63.7B
$21.1M 0.12%
492,613
+120,796
+32% +$5.1M
5 6
7
8 9

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.